Ang II activation of AT1 receptor signalling mediates several key events of the inflammatory processes, such as nuclear factor-κB activation, which results in the release of proinflammatory cytokines and inducible nitric oxide synthase (iNOS). 11, 12 The AT1 receptor is ubiquitously expressed in the cardiovascular system and mediates most of the physiological and pathophysiological actions of Ang II. 13 Angiotensin-converting enzyme 2 (ACE2) has emerged as a key player in the pathophysiology of hypertension and cardiovascular and renal disease. 14 Increased ACE2 levels are a compensatory mechanism to impede a progression of heart failure, keeping in mind that ACE2 overexpression provided cardioprotection in rats subjected to myocardial infarction. 15 Accordingly, AT1 signalling blockers, including olmesartan, have been shown to have antioxidant and anti-inflammatory activities in different experimental models. 16, 17 The blockade of angiotensin II receptor type 1 by olmesartan can attenuate the inflammatory effect of angiotensin II in this AT 1 receptor, which would result in a possible reduction in ACE2 gene expression, and consequently control the inflammatory process. However, as far as we know, the effects of olmesartan (Olme) on OM have not been reported in the literature; therefore, in the present study we examined a possible protective effect of this drug on 5-FU-induced OM in hamsters.
| MATERIALS AND METHODS

| Animals
The experimental model of 5-FU-induced OM was performed in male Golden Syrian hamsters (Mesocricetus auratus, n = 50) weighing approximately 140 g at the age of 3 months old. The hamsters were kept under controlled 12-hour light/dark cycle, humidity (45%-55%) and temperature (20-22°C) conditions. They had free access to standardized rodent food and water. The experimental protocol was approved by the Research Ethics Committee CEUA/UFRN protocol No. 14/2016.
| Experimental OM, Olme treatment and study groups
The experimental OM was induced by an intraperitoneal (i.p.) injection by using a gavage cannula for 10 days. Treatment control animals were given saline instead of olmesartan medoxomil (Olme).
At day 10, hamsters were euthanized by i.p. injection of 2% thiopental (100 mg/kg) and blood and tissue samples were collected for subsequent analyses.
Hamsters were randomly divided into six experimental groups 
| Experimental outcomes
The behaviour and deaths of animals were recorded during the experiment.
| Macroscopic analysis of the oral mucosa
After euthanasia, oral mucosa tissue samples were photographed for macroscopic analysis. The parameters evaluated were the presence and intensity of erythema, hyperaemia, haemorrhage, ulcers and abscesses, which were scored as described previously. 6 Briefly, the scoring rubric was as follows: 0, completely healthy cheek pouch with no erosion or vasodilatation; 1, erythema without evidence of erosion in the cheek pouch; 2, severe erythema, vasodilation and surface erosion; 3, severe erythema and vasodilatation with ulcers in one or more faces of the mucosa affecting <25% of the surface area of the cheek pouch; 4, cumulative ulcers affecting at least 25%-50%
of the surface area of the cheek pouch; and 5, virtually complete ulceration of the cheek pouch mucosa, in which the fibrosis makes oral mucosa exposure difficult.
| Histopathology
Specimens (n = 5/group) fixed in 10% neutral buffered formalin were dehydrated and embedded in paraffin. Ultrathin sections (5-μm) were stained with haematoxylin and eosin and examined by light microscopy (40× magnification). Inflammatory cell infiltration, vasodilatation, the presence of haemorrhage, oedema, ulcerations and abscesses were determined in a single-blinded fashion and graded as follows: Score 1, normal epithelium and connective tissue without vasodilatation, absence of or discreet cellular infiltration, and absence of haemorrhagic areas, ulcerations or abscesses; Score 2, discreet vasodilatation or re-epithelization areas, discreet inflammatory infiltration with mononuclear prevalence, and absence of haemorrhagic areas, oedema, ulcerations or abscesses; Score 3, moderate vasodilatation, areas of hydropic epithelial degeneration, inflammatory infiltration with neutrophil prevalence, presence of haemorrhagic areas, oedema and eventual ulceration, and absence of abscesses; and Score 4, severe vasodilatation, and inflammatory infiltration with neutrophil and presence of abscesses.
| Immunohistochemical analysis
Sections of 4 μm (n = 5/group) were prepared from paraffin- 
| GSH assay
| Cytokine immunoassays
Samples of oral mucosa (n = 4/group) were homogenized and processed. Briefly, we determined interleukin (IL)-1β (detection range, 62.5-4000 pg/mL; minimum detection limit, 12.5 ng/mL) and tumour necrosis factor (TNF)-α (detection range, 62.5-4000 pg/mL; minimum detection limit, 50 ng/mL) levels using commercial enzyme- 
| Immunoblotting
Oral mucosa tissue samples (n = 5/group) were homogenized in RIPA lysis buffer (25 mmol/L Tris-HCL, pH 7.6; 150 mmol/L NaCl; 5 mmol/ L EDTA; 1% NP40; 1% triton X-100; 1% sodium deoxycholate; 0.1% sodium dodecyl sulfate-polyacrylamide) and protease inhibitor (1 μL in 100 μL RIPA). After centrifugation (17 minutes, 4°C, 18 928 g), 
| 975
ChemiDoc ™ XRS system (Bio-Rad) and quantified densitometrically in ImageJ software (NIH).
| Leucocyte quantitation, biochemical analysis and bacteraemia analysis
Serum (n = 10/group) was obtained by centrifuging total blood without anticoagulants at 700 g for 15 minutes. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine and urea were determined with standardized diagnostic kits (LABT-EST ® ) and spectrophotometry.
For leucocyte counts (n = 10/group), 20-μL samples of total blood were combined with 380 μL of Turk solution. Total counts of leucocytes per mm³ were determined by standard manual light microscopy procedures. 18 For bacteraemia analysis (n = 5/group), 10-μL samples of total blood were diluted 10-fold in brain-heart infusion media. Bacterial growth was analysed after 24 and 48 hours at 37°C by visual analysis of culture medium turbidity; wherein, the presence of turbidity indicated positivity for bacteraemia. 3 | RESULTS
| Statistical analysis
| Effects of Olme treatment on 5-FU-induced oral mucosal lesions and histopathology alterations
Normal group showed completely healthy cheek pouch with no erosion or vasodilatation in macroscopical aspects 0 (0-0, P < 0.001) and normal epithelium and connective tissue without vasodilatation, absence of or discreet cellular infiltration and absence of haemorrhagic areas, ulcerations or abscesses in histopathological analysis 1
(1-1, P < 0.001), compared with 5-FUT/saline group, Figure 1A (macroscopical analysis), Figure 1A ,E,I (histopathological analysis), Table 1 . MT group showed erythema, vasodilation and surface erosion in macroscopical aspects 2 (1.5-3, P < 0.05) and discreet vasodilatation or re-epithelization areas, discreet inflammatory infiltration with mononuclear prevalence and absence of haemorrhagic areas, oedema, ulcerations or abscesses in histopathological analysis 2 (2-2, P < 0.01) compared with 5-FUT/saline group, Figure 1B (macroscopical analysis), Figure 1B ,F,J (histopathological analysis), Table 1 Figure 2D and H/ histopathological analysis, respectively).
As shown in Table 1 
| Oxidative stress
As shown in Figure 2 , the Olme 10 group had less (P < 0.01) intense SOD labelling in cheek tissue specimens than the 5-FUT/saline group.
F I G U R E 1 Macroscopic analysis (n = 10/group) of normal group (animals with healthy oral with no erosion or vasodilatation of hamster cheek pouch tissue) (A); tissue subjected to mechanic trauma/TM group (B) (erythema, vasodilation and surface erosion in the jugal mucosa); 5-FUT/saline group (C), showing erythema, hyperaemia, haemorrhagic areas and extensive ulceration on the oral mucosa; and cheek pouch tissues treated with Olme 1 mg/kg (erythema, hyperaemia, haemorrhagic areas and extensive ulceration) (D), Olme 5 mg/kg (erythema, hyperaemia, haemorrhagic areas and extensive ulceration) (E) and Olme 10 mg/kg (less severe lesions, with discrete erythema but no ulcers) (F). Histophatological analysis of hamster cheek pouches (n = 5/group). Normal group (normal epithelium and connective tissue without vasodilatation, absence of or discreet cellular infiltration and absence of haemorrhagic areas, ulcerations or abscesses) (A,E,I); mechanic trauma (TM) control (discreet vasodilatation or re-epithelization areas, discreet inflammatory infiltration with mononuclear prevalence and absence of haemorrhagic areas, oedema, ulcerations or abscesses) (B,F,J); 5-FUT/saline group (severe vascular ingurgitation and vasodilatation, accentuated inflammatory cells infiltrate with a prevalence of neutrophils, oedema and extensive ulceration with abscesses) (C,G,K); and Olme 1 mg/kg (prevalence of neutrophils, oedema, ulcers and abscesses) (D), Olme 5 mg/kg (prevalence of neutrophils, oedema, ulcers and abscesses) (H) or Olme 10 mg/kg (reduced cellular inflammation, oedema and haemorrhage, although granulation tissue was present) (L). Arrows; ulcers presence; Two Triangle indicates moderate and intense cells inflammatory. One Triangle indicates low cells inflammatory; Star: re-epithelialization area.
Images are shown at 40× magnification. Bar = 100 μm As shown in Figure 3 , the MDA levels, an indicator of lipid peroxidation, were also decreased in the Normal and Olme 10 mg/kg group tissue samples relative to that in both the 5FUT/saline group (P < 0.01 and P < 0.05, respectively). Conversely, GSH levels in the normal group and Olme 10 mg/kg group were increased relative to that in the 5-FUT/saline group (P < 0.05) (Figure 3 ).
| Expression of enzymes, proteins and genes involved in inflammation and formation of granulation tissue
Increases in MPO activity induced by 5-FUT/saline on the oral mucosa were reversed (P < 0.05) with Olme 10 mg/kg, (Figure 3 ).
Levels of IL-1β and TNF-α were increased on the oral mucosa of hamsters of the 5-FUT/saline group compared with normal group (P < 0.05 and P < 0.001, respectively; Figure 3 ). These increases were countered significantly with Olme 10 mg/kg in the case of TNF-α (P < 0.01), and with either Olme 5 mg/kg or Olme 10 mg/kg were observed decreases in levels of IL-1β, (P < 0.05), (Figure 3 ).
Olme treatment effects on MO-induced changes in IHC markers
were apparent with Olme 10 mg/kg. Likewise, the Olme 10 mg/kg treatment resulted in more intense FGF-2, and TGF-β immunopositivity relative to the normal group, P < 0.05 (Figure 2 ). The Olme 10 mg/kg showed weak immunopositivity relative for MMP-2, (P < 0,05, Figure 2 ).
Olme 10 mg/kg, but not Olme 1 mg/kg or Olme 5 mg/kg, reduced the MO model-associated decreased in IL-1β and TNF-α mRNA (P < 0.001, Figure 4A ). Olme 10 mg/kg reduced expression of NFκBp65 relative to that in 5-FU group (P < 0.001 and P < 0.05, respectively, Figure 4A ). Olme 10 mg/kg reduced expression of MKP1 compared with 5-FUT/saline group (P < 0.001, Figure 4A ).
ACE2 mRNA levels appeared to be lower in the Olme 10 mg/kg group (*P < 0.05) and Normal (***P < 0.001) group compared to the 5FUT/saline group.
Relative to the normal group, ERK2 (Figure 4B 
| Systemic effects of Olme
Levels of hepatic enzymes (ALT and AST) and markers of renal function (urea and creatinine) did not differ significantly among the groups (Table 1 ). The 5-FUT/saline (25 000 + 11 174 mm 3 ), but not the Olme treated groups, had significantly increased leucocyte levels compared to the normal group (P < 0.001; Table 1 ).
The bacteraemia analysis results of each group are reported in Table 1 . Briefly, the Normal control only one sample exhibit bacteraemia, whereas the 5-FUT/saline group, Olme 1 mg/kg, Olme 5 mg/ kg and Olme 10 groups did exhibit bacteraemia (+).
| Experimental outcomes
No records of behaviour change or death were found during the animal experiment models.
T A B L E 1 Macroscopic score (n = 10/group), histopathological score (n = 5/group), number of leucocytes-WBCs/mm³ (n = 10/group) and quantify of blood sample/number of positive turbidity (n = 5/group) analysis of hamsters cheek pouches subjected of experimental oral mucositis Determination of the alanine aminotransferase (ALT) and aspartate aminotransferase (AST), urea and creatinine parameters biochemistry of experimental oral mucositis (n = 10/group) determined with standardized diagnostic kits (LABTEST ® ) and spectrophotometry. The scores are represented with the standard error of the mean. *P < 0.001 compared groups with normal group. **P < 0.05, ***P < 0.01 compared groups with the 5-FUT/saline group (ANOVA test followed by Bonferroni's test). Natal, RN, 2018. This finding was correlated with a significant decrease in inflammatory infiltration, haemorrhagic areas, oedema, ulcerations and abscesses.
Groups
F I G U R E 3 Myeloperoxidase (MPO) (n = 4/group) activity, malondialdehyde (MDA) (n = 4/group) and glutathione (GSH) (n = 4/group) levels, levels of IL-1β (n = 4/group) and TNF-α (n = 4/group) in Normal, 5-FUT/saline, Olme 1 mg/kg, Olme 5 mg/kg and Olme 10 mg/kg groups (*P < 0.05, **P < 0.01, ***P < 0.001)
F I G U R E 4 A, Olme effects on IL-1β, TNF-α, NF-κBp65, MKP1
and ACE2 mRNA expression in hamster cheek pouches (n = 5/group). The expression of IL-1β and TNF-α mRNA was decreased in Normal and Olme 10 mg/kg groups (***P < 0.001). The expression of NF-κBp65 mRNA was decreased in Normal and Olme 10 mg/kg groups (***P < 0.001). MPK1 decreased in Normal and Olme 10 mg/kg (***P < 0.001) groups. ACE2mRNA levels appeared to be lower in the Olme 10 mg/kg group (*P < 0.05) and Normal (***P < 0.001) group compared to the 5FUT/ saline group. (N = 4 animals per group; Duplicate analysis, ANOVA test followed by Bonferroni). B, Representative images of immunoblotting of nitric oxide synthase-iNOS-and extracellular regulated kinase (ERK)1/2 (n = 5/group). The bands were visualized with an ECL system applied according to the manufacturer's instructions (Bio-Rad). Another important finding is that ACE2 overexpression attenuated myocardial fibrosis, improved left ventricular remodelling and cardiac function, improved pathological symptoms and decreased the mortality of rats. 27 Increased ACE2 levels are a compensatory mechanism to impede progression of heart failure. 15 Thus, the increase in ACE2
is directly related to the pathology by a compensatory mechanism that prevents the progression of the disease. 27 In our study, the effect was apparently related to the increase in ACE2 in the pathology as a compensatory mechanism to prevent the progression of the oral mucositis. These data can be confirmed in the 5-FUT/saline group and in the treated groups at the lower doses of olmesartan 1 and 5 mg/kg, which were also submitted to 5-FU.
Low doses of olmesartan (1 and 5 mg/kg) were not able to inhibit oxidative stress and inflammatory process related to chemotherapy, F I G U R E 5 Representative confocal photomicrographs of migration inhibitory factor (MIF), IL-10, IL-1β and TNF-α immunoreactivity in hamster cheek pouch specimens from each group (green) with DAPI nuclear counterstained (blue) (n = 5/group). Normal control hamster cheek pouches present MIF and IL-10 labelling, showing weak and middle labelling, respectively. Weak IL-10 labelling and strong MIF labelling were seen in the 5-FUT/saline group. IL-10 labelling was diffuse and strong in the Olme 10 mg/kg group, and weak MIF labelling was seen in the Olme 10 mg/kg group. Densitometric analysis confirmed significant increases in IL-10 and decreased in MIF immunoreactivity in the Olme (10 mg/kg) that were blocked in the 5-FUT/saline group (***P < 0.001). Normal control hamster cheek pouches present IL-1β and TNF-α labelling, showing weak labelling; strong IL-1β and TNF-α labelling were seen in the 5-FUT/saline group. IL-1β and TNF-α labelling were diffuse and weak in the Olme 10 mg/kg group. Five immunofluorescence sections from each animal in each group were analysed (N = 3 animals per group) (***P < 0.001, Kruskal-Wallis test followed by Dunn's test). Scale bar, 50 μm, 20×
and there was no need for a compensatory increase in ACE2 gene expression. However, the group treated at the highest dose of olmesartan (10 mg/kg) and submitted to 5-FU presented clinical, histopathological and molecular results of a significant reduction in oral mucositis. The effect of olmesartan (10 mg/kg) was to prevent oxidative stress, and consequently the inflammatory process, so there was no need for a compensatory increase in ACE2 gene expression.
ACE2 directly hydrolyses Ang II to Ang(1-7). Ang(1-7) is a biologically active metabolite that counterbalances the cardiovascular effects of Ang II. Through the Mas receptor, Ang(1-7) exerts vasodilatory and antiproliferative effects, therefore, counter balancing Ang II.
The levels of Ang (1-7) is ACE2-dependent. 14 Thus, treatment with olmesartan at a dose of 10 mg/kg reduced oxidative stress and inflammation in oral mucositis and downregulation of ACE2, possibly there were regulation levels of angiotensin 1-7 in this group.
The inducible, Ca2+-independent enzyme iNOS is expressed in target tissues after stimulation with endotoxin and cytokines. Ang II could modulate NO production by cardiac myocytes. Although Ang II alone had no effect on nitrite production, it markedly augmented IL- 
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